Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Jianfei Qi"'
Autor:
Qian Liu, Emma Adhikari, Daniel K. Lester, Bin Fang, Joseph O. Johnson, Yijun Tian, Andrea T. Mockabee-Macias, Victoria Izumi, Kelly M. Guzman, Michael G. White, John M. Koomen, Jennifer A. Wargo, Jane L. Messina, Jianfei Qi, Eric K. Lau
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-20 (2024)
Abstract Melanoma incidence and mortality rates are historically higher for men than women. Although emerging studies have highlighted tumorigenic roles for the male sex hormone androgen and its receptor (AR) in melanoma, cellular and molecular mecha
Externí odkaz:
https://doaj.org/article/1d6b5538888248d5b44646f3fe07e1be
Publikováno v:
Virology Journal, Vol 19, Iss 1, Pp 1-9 (2022)
Abstract Background Betanodaviruses, members of the Nodaviridae family, are the causative agents of viral nervous necrosis in fish, resulting in great economic losses worldwide. Methods In this study, we isolated a virus strain named seahorse nervous
Externí odkaz:
https://doaj.org/article/85f3e4abc21442b5b2d702c6e1e1421e
Autor:
Jie Wu, Chunlei Zheng, Yizhe Wang, Zichang Yang, Ce Li, Wanxia Fang, Yue Jin, Kezuo Hou, Yang Cheng, Jianfei Qi, Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Xuejun Hu
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/c4392cc1a5b74d0aa77743c3d791fc92
Autor:
Jie Wu, Chunlei Zheng, Yizhe Wang, Zichang Yang, Ce Li, Wanxia Fang, Yue Jin, Kezuo Hou, Yang Cheng, Jianfei Qi, Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Xuejun Hu
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-17 (2021)
Abstract Background Epidermal growth factor receptor-tyrosinase kinase inhibitor (EGFR-TKI) resistance is the major obstacle in the treatment of lung adenocarcinoma (LUAD) patients harboring EGFR-sensitive mutations. However, the long non-coding RNAs
Externí odkaz:
https://doaj.org/article/d0c4a1b3e17447dc96c07e9a6b8da4f1
Autor:
Duo Wang, Xiujuan Qu, Wenqing Lu, Yizhe Wang, Yue Jin, Kezuo Hou, Bowen Yang, Ce Li, Jianfei Qi, Jiawen Xiao, Xiaofang Che, Yunpeng Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Abnormal RNA m6A methylation is known to lead to the occurrence and progression of multiple cancers including gastric cancer (GC). However, the integrative effects of all m6A methylation regulators on GC prognosis are unclear. Our research aimed to g
Externí odkaz:
https://doaj.org/article/d5218952dd4b481a9bcbc00818125749
Autor:
Yang Cheng, Kezuo Hou, Yizhe Wang, Yang Chen, Xueying Zheng, Jianfei Qi, Bowen Yang, Shiying Tang, Xu Han, Dongyao Shi, Ximing Wang, Yunpeng Liu, Xuejun Hu, Xiaofang Che
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundLung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, with high incidence and mortality. To improve the curative effect and prolong the survival of patients, it is necessary to find new biomarkers to accurately pre
Externí odkaz:
https://doaj.org/article/44deb620b25d4e249dc67ce2c778b372
Autor:
Lingling Jiang, Yan Qi, Xianghan Kong, Runnan Wang, Jianfei Qi, Francis Lin, Xueling Cui, Zhonghui Liu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Activin A, a member of the transforming growth factor-beta (TGF-β) superfamily, contributes to tissue healing and fibrosis. As the innate tissue cells, fibroblasts also play an important role in wound healing and fibrosis. Herein, this study was aim
Externí odkaz:
https://doaj.org/article/26aae5b9da31460eb1e726c421e2f988
Autor:
Yizhe Wang, Chunlei Zheng, Wenqing Lu, Duo Wang, Yang Cheng, Yang Chen, Kezuo Hou, Jianfei Qi, Yunpeng Liu, Xiaofang Che, Xuejun Hu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) greatly benefit from EGFR-tyrosine kinase inhibitors (EGFR-TKIs) while the prognosis of patients who lack EGFR-sensitive mutations (EGFR wild type, EGFR-WT) remains poor due to a lack of ef
Externí odkaz:
https://doaj.org/article/26d540bf9ee2403599d033445e780183
Autor:
Victor M. Matias-Barrios, Mariia Radaeva, Yi Song, Zaccary Alperstein, Ahn R. Lee, Veronika Schmitt, Joseph Lee, Fuqiang Ban, Ning Xie, Jianfei Qi, Nada Lallous, Martin E. Gleave, Artem Cherkasov, Xuesen Dong
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Poison inhibitors of DNA topoisomerase II (TOP2) are clinically used drugs that cause cancer cell death by inducing DNA damage, which mechanism of action is also associated with serious side effects such as secondary malignancy and cardiotoxicity. In
Externí odkaz:
https://doaj.org/article/e540c6f93470479eae4a4308cd7ca9c6
Autor:
Wenqing Lu, Xiaofang Che, Xiujuan Qu, Chunlei Zheng, Xianghong Yang, Bowen Bao, Zhi Li, Duo Wang, Yue Jin, Yizhe Wang, Jiawen Xiao, Jianfei Qi, Yunpeng Liu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Succinylation is a newly discovered and multienzyme-regulated post-translational modification (PTM) that is associated with the initiation and progression of cancer. Currently, no systematic analyses on the role of succinylation regulators in tumors
Externí odkaz:
https://doaj.org/article/451876d4143d4f6c9cc9bb90d3e21ddc